Key Takeaway
Exclusive: Fears that US companies may withdraw more medecines as global markets react to policy changes by the Trump administrationA “life saving” drug heavily subsidised for Australians living with opioid dependency will be pulled from the market by the end of the year, causing alarm among doctors and pharmacists. US pharmaceutical company Indivior confirmed the marketing and sale of the…
Published July 1, 2026 · Category: News
Overview
Exclusive: Fears that US companies may withdraw more medecines as global markets react to policy changes by the Trump administration
A “life saving” drug heavily subsidised for Australians living with opioid dependency will be pulled from the market by the end of the year, causing alarm among doctors and pharmacists.
Details
US pharmaceutical company Indivior confirmed the marketing and sale of the long-acting injectable prescription opioid Sublocade would end from 31 December, with a company spokesperson describing it as a “commercial decision”.
Continue reading...
Source
Originally published at www.theguardian.com.
Related Articles
Frequently Asked Questions
What is "‘Life saving’ drug for people with opioid dependency to be pulled from Australia by end of year" about?+
Exclusive: Fears that US companies may withdraw more medecines as global markets react to policy changes by the Trump administrationA “life saving” drug heavily subsidised for Australians living with opioid dependency will be pulled from the market by the end of the year, causing alarm among doctors and pharmacists.US pharmaceutical company Indivior confirmed the marketing and sale of the long-acting injectable prescription opioid Sublocade would end from 31 December, with a company spokesperson
Who reported this story?+
This story was reported by The Guardian World.